Canadian and US drug approval times and safety considerations - PubMed
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Background: Approval times of new drugs are frequently longer in Canada than in the US, but it has been argued that reducing approval times might lead to unsafe drugs receiving marketing approval. Objective: To compare new drug approval times in Canada and the US over a 10-year period and to relate them to safety discontinuations. Methods: Application and approval dates of all new drugs except diagnostic products, new salts, esters, isomers, and dosage forms of already-marketed drugs, as well as combinations containing previously approved substance
Canadian and US drug approval times and safety considerations - PubMed Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Searc
Explore this link on the map →related reading
- The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
- Why the FDA Is Slow to Remove Drugspress.asimov.com
- Product-Specific Regulatory Pathways to Approve Generic Drugs: The Need for Follow-up Studies to Ensure Safety and Effectiveness - PubMedpubmed.ncbi.nlm.nih.gov
- The Secret Gamble at the FDA That Exposed Americans to Risky Drugs — ProPublicapropublica.org
- Checking your browser - reCAPTCHAncbi.nlm.nih.gov
- Who regulates the regulators?rootsofprogress.org
- Drug Commercialization Process: From Research to Marketbiotechprimer.com
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- Pearl Freier on X: "Cell & gene therapies were 2.5x more likely to receive FDA approval after entering Phase 1 than other drug types according to research by the NEWDIGs initiative at Tufts Medical Center h/t @DrPHanley & @alliancerm . @NatRevDrugDisc paper below 1/n https://t.co/DN4k7qWrAt" / Xx.com
- Biotech’s Lost Archive | IFPifp.org
- Biotech’s Lost Archive | IFPifp.org
- FDA Announces Major Steps to Implement Real-Time Clinical Trials | FDAfda.gov